The effects of trastuzumab, paclitaxel, and carboplatin on HER2-positive cancer stem cells that are isolated from primary breast cancer cultures: a preliminary report

Artac, MehmetKayadibi, GozdeCeylan, AycaKars, Meltem DemirelArtac, HasibeCakir, MuratBoruban, Cem2020-03-262020-03-2620150008-54721538-7445https://dx.doi.org/10.1158/1538-7445.AM2015-718https://hdl.handle.net/20.500.12395/32650106th Annual Meeting of the American-Association-for-Cancer-Research (AACR) -- APR 18-22, 2015 -- Philadelphia, PA[Abstract not Available]en10.1158/1538-7445.AM2015-718info:eu-repo/semantics/closedAccessThe effects of trastuzumab, paclitaxel, and carboplatin on HER2-positive cancer stem cells that are isolated from primary breast cancer cultures: a preliminary reportConference Object75WOS:000371578501174Q1